Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RoseStreet Labs is a technology development company based in Phoenix, Arizona, that specializes in the commercialization of advanced semiconductor materials for the energy, wireless, and life sciences sectors. Through its RSL Life Sciences division, the company develops high-sensitivity biosensors utilizing proprietary Group III-Nitride thin-film technology. This platform is engineered for the real-time detection of biological and chemical agents, providing a robust solution for point-of-care diagnostics and environmental monitoring. The company operates as a "venture lab," collaborating with national laboratories and academic institutions to transition early-stage research into scalable commercial applications. Its life sciences portfolio focuses on leveraging material science to improve the speed and accuracy of pathogen detection. RoseStreet Labs maintains a strong emphasis on intellectual property and strategic partnerships to drive its innovation pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RoseStreet Labs.